Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (27)
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, Guido Kroemer & Jonathan G. Pol. (2021) Trial watch: intratumoral immunotherapy. OncoImmunology 10:1.
Read now
Read now
Laura V Ashton, Barbara Graham, Maryam F Afzali, Daniel Gustafson & Amy L MacNeill. (2020) Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib. Oncolytic Virotherapy 9, pages 17-29.
Read now
Read now
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now
Read now
Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now
Read now
Chin Liang Lee, Sanggeetha Veeramani, Aidin Molouki, Swee Hua Erin Lim, Warren Thomas, Suet Lin Chia & Khatijah Yusoff. (2019) Virotherapy: Current Trends and Future Prospects for Treatment of Colon and Rectal Malignancies. Cancer Investigation 37:8, pages 393-414.
Read now
Read now
Jonathan G Pol, Matthew J Atherton, Byram W Bridle, Kyle B Stephenson, Fabrice Le Boeuf, Jeff L Hummel, Chantal G Martin, Julia Pomoransky, Caroline J Breitbach, Jean-Simon Diallo, David F Stojdl, John C Bell, Yonghong Wan & Brian D Lichty. (2018) Development and applications of oncolytic Maraba virus vaccines. Oncolytic Virotherapy 7, pages 117-128.
Read now
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now
Read now
Dörthe Masemann, Katharina Köther, Meike Kuhlencord, Georg Varga, Johannes Roth, Brian Dennis Lichty, Ulf Rüdiger Rapp, Viktor Wixler & Stephan Ludwig. (2018) Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages. OncoImmunology 7:5.
Read now
Read now
KJ Allan, David F Stojdl & SL Swift. (2016) High-throughput screening to enhance oncolytic virus immunotherapy. Oncolytic Virotherapy 5, pages 15-25.
Read now
Read now
Patricia Kleinpeter, Laetitia Fend, Christine Thioudellet, Michel Geist, Nathalie Sfrontato, Véronique Koerper, Catherine Fahrner, Doris Schmitt, Murielle Gantzer, Christelle Remy-Ziller, Renée Brandely, Dominique Villeval, Karola Rittner, Nathalie Silvestre, Philippe Erbs, Laurence Zitvogel, Eric Quéméneur, Xavier Préville & Jean-Baptiste Marchand. (2016) Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition. OncoImmunology 5:10.
Read now
Read now
Erika Vacchelli, Norma Bloy, Fernando Aranda, Aitziber Buqué, Isabelle Cremer, Sandra Demaria, Alexander Eggermont, Silvia Chiara Formenti, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch: Immunotherapy plus radiation therapy for oncological indications. OncoImmunology 5:9.
Read now
Read now
Mikko Siurala, Markus Vähä-Koskela, Riikka Havunen, Siri Tähtinen, Simona Bramante, Suvi Parviainen, J. Michael Mathis, Anna Kanerva & Akseli Hemminki. (2016) Syngeneic Syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting. OncoImmunology 5:5.
Read now
Read now
Zuqiang Liu, Roshni Ravindranathan, Jun Li, Pawel Kalinski, Z. Sheng Guo & David L. Bartlett. (2016) CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy. OncoImmunology 5:3.
Read now
Read now
Jonathan Pol, Aitziber Buqué, Fernando Aranda, Norma Bloy, Isabelle Cremer, Alexander Eggermont, Philippe Erbs, Jitka Fucikova, Jérôme Galon, Jean-Marc Limacher, Xavier Preville, Catherine Sautès-Fridman, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Oncolytic viruses and cancer therapy. OncoImmunology 5:2.
Read now
Read now
Erika Vacchelli, Fernando Aranda, Norma Bloy, Aitziber Buqué, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Immunostimulation with cytokines in cancer therapy. OncoImmunology 5:2.
Read now
Read now
Jonathan Pol, Guido Kroemer & Lorenzo Galluzzi. (2016) First oncolytic virus approved for melanoma immunotherapy. OncoImmunology 5:1.
Read now
Read now
Jean-François Fonteneau, Carole Achard, Cécile Zaupa, Johann Foloppe & Philippe Erbs. (2016) Oncolytic immunotherapy: The new clinical outbreak. OncoImmunology 5:1.
Read now
Read now
Amy L MacNeill. (2015) On the potential of oncolytic virotherapy for the treatment of canine cancers. Oncolytic Virotherapy 4, pages 95-107.
Read now
Read now
James J Cody & Douglas R Hurst. (2015) Promising oncolytic agents for metastatic breast cancer treatment. Oncolytic Virotherapy 4, pages 63-73.
Read now
Read now
Jian Qiao, Mahua Dey, Alan L Chang, Julius W Kim, Jason Miska, Alex Ling, Dirk M Nettlebeck, Yu Han, Lingjiao Zhang & Maciej S Lesniak. (2015) Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy. OncoImmunology 4:8.
Read now
Read now
Tanja D de Gruijl, Axel B Janssen & Victor W van Beusechem. (2015) Arming oncolytic viruses to leverage antitumor immunity. Expert Opinion on Biological Therapy 15:7, pages 959-971.
Read now
Read now
Norma Bloy, Aitziber Buqué, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology 4:5.
Read now
Read now
Jonathan Pol, Erika Vacchelli, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. OncoImmunology 4:4.
Read now
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Aurélien Marabelle, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. OncoImmunology 4:4.
Read now
Read now
Mohan Babu Appaiahgari & Sudhanshu Vrati. (2015) Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls. Expert Opinion on Biological Therapy 15:3, pages 337-351.
Read now
Read now
Lorenzo Galluzzi, Guido Kroemer & Alexander Eggermont. (2014) Novel immune checkpoint blocker approved for the treatment of advanced melanoma. OncoImmunology 3:11.
Read now
Read now
Oliver Kepp, Laura Senovilla, Ilio Vitale, Erika Vacchelli, Sandy Adjemian, Patrizia Agostinis, Lionel Apetoh, Fernando Aranda, Vincenzo Barnaba, Norma Bloy, Laura Bracci, Karine Breckpot, David Brough, Aitziber Buqué, Maria G. Castro, Mara Cirone, Maria I. Colombo, Isabelle Cremer, Sandra Demaria, Luciana Dini, Aristides G. Eliopoulos, Alberto Faggioni, Silvia C. Formenti, Jitka Fučíková, Lucia Gabriele, Udo S. Gaipl, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Nathalia A. Giese, Zong Sheng Guo, Akseli Hemminki, Martin Herrmann, James W. Hodge, Stefan Holdenrieder, Jamie Honeychurch, Hong-Min Hu, Xing Huang, Tim M. Illidge, Koji Kono, Mladen Korbelik, Dmitri V. Krysko, Sherene Loi, Pedro R. Lowenstein, Enrico Lugli, Yuting Ma, Frank Madeo, Angelo A. Manfredi, Isabelle Martins, Domenico Mavilio, Laurie Menger, Nicolò Merendino, Michael Michaud, Gregoire Mignot, Karen L. Mossman, Gabriele Multhoff, Rudolf Oehler, Fabio Palombo, Theocharis Panaretakis, Jonathan Pol, Enrico Proietti, Jean-Ehrland Ricci, Chiara Riganti, Patrizia Rovere-Querini, Anna Rubartelli, Antonella Sistigu, Mark J. Smyth, Juergen Sonnemann, Radek Spisek, John Stagg, Abdul Qader Sukkurwala, Eric Tartour, Andrew Thorburn, Stephen H. Thorne, Peter Vandenabeele, Francesca Velotti, Samuel T. Workenhe, Haining Yang, Wei-Xing Zong, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Consensus guidelines for the detection of immunogenic cell death. OncoImmunology 3:9.
Read now
Read now
Articles from other publishers (62)
Joseph Willis, Robert A. Anders, Toshihiko Torigoe, Yoshihiko Hirohashi, Carlo Bifulco, Inti Zlobec, Bernhard Mlecnik, Sandra Demaria, Won-Tak Choi, Pavel Dundr, Fabiana Tatangelo, Annabella Di Mauro, Pamela Baldin, Gabriela Bindea, Florence Marliot, Nacilla Haicheur, Tessa Fredriksen, Amos Kirilovsky, Bénédicte Buttard, Angela Vasaturo, Lucie Lafontaine, Pauline Maby, Carine El Sissy, Assia Hijazi, Amine Majdi, Christine Lagorce, Anne Berger, Marc Van den Eynde, Franck Pagès, Alessandro Lugli & Jérôme Galon. (2023) Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore. Cancers 15:16, pages 4045.
Crossref
Crossref
Nadia Ghasemi Darestani, Anna I. Gilmanova, Moaed E. Al-Gazally, Angelina O. Zekiy, Mohammad Javed Ansari, Rahman S. Zabibah, Mohammed Abed Jawad, Saif A. J. Al-Shalah, Jasur Alimdjanovich Rizaev, Yasir S. Alnassar, Naseer Mihdi Mohammed, Yasser Fakri Mustafa, Mohammad Darvishi & Reza Akhavan-Sigari. (2023) Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment. Cell Communication and Signaling 21:1.
Crossref
Crossref
Ali Zarezadeh Mehrabadi, Fatemeh Roozbahani, Reza Ranjbar, Mahdieh Farzanehpour, Alireza Shahriary, Ruhollah Dorostkar & Hadi Esmaeili Gouvarchin Ghaleh. (2022) Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses. World Journal of Surgical Oncology 20:1.
Crossref
Crossref
Lars M. Howell & Neil S. Forbes. (2022) Bacteria-based immune therapies for cancer treatment. Seminars in Cancer Biology 86, pages 1163-1178.
Crossref
Crossref
Haruko Tashiro, Lauren Scherer & Malcolm Brenner. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
11
.
Jiawen Huang, Xiaobing Huang & Juan Huang. (2022) CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies. Frontiers in Immunology 13.
Crossref
Crossref
YANG WANG, JING JIN, YUYING LI, QIN ZHOU, RUOYI YAO, ZHEN WU, HAN HU, ZHIZHENG FANG, SHUANG DONG, QIAN CAI, SHENG HU & BINLEI LIU. (2022) NK cell tumor therapy modulated by UV-inactivated oncolytic herpes simplex virus type 2 and checkpoint inhibitors. Translational Research 240, pages 64-86.
Crossref
Crossref
Michail Galanopoulos, Aris Doukatas, Filippos Gkeros, Nikos Viazis & Christos Liatsos. (2021) Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy. World Journal of Gastroenterology 27:24, pages 3568-3580.
Crossref
Crossref
Masahiro Kagabu, Naoto Yoshino, Tatsunori Saito, Yuki Miura, Ryosuke Takeshita, Kazuyuki Murakami, Hideki Kawamura, Tsukasa Baba & Toru Sugiyama. (2020) The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model. International Journal of Clinical Oncology 26:3, pages 591-597.
Crossref
Crossref
Jonathan G. Pol, Samuel T. Workenhe, Prathyusha Konda, Shashi Gujar & Guido Kroemer. (2020) Cytokines in oncolytic virotherapy. Cytokine & Growth Factor Reviews 56, pages 4-27.
Crossref
Crossref
Sohini Roy, Tarsheen K. Sethi, David Taylor, Young J. Kim & Douglas B. Johnson. (2020) Breakthrough concepts in immune‐oncology: Cancer vaccines at the bedside. Journal of Leukocyte Biology 108:4, pages 1455-1489.
Crossref
Crossref
Yao Huang, Sai‐qun Lv, Pin‐yi Liu, Zhen‐long Ye, Huan Yang, Lin‐fang Li, Hai‐li Zhu, Ying Wang, Lian‐zhen Cui, Du‐qing Jiang, Fang‐yuan Hao, Hui‐min Xu, Hua‐jun Jin & Qi‐jun Qian. (2020) A SIRPα‐Fc fusion protein enhances the antitumor effect of oncolytic adenovirus against ovarian cancer. Molecular Oncology 14:3, pages 657-668.
Crossref
Crossref
Masaya Igase, Shusaku Shibutani, Yosuke Kurogouchi, Noriyuki Fujiki, Chung Chew Hwang, Matt Coffey, Shunsuke Noguchi, Yuki Nemoto & Takuya Mizuno. (2019) Combination Therapy with Reovirus and ATM Inhibitor Enhances Cell Death and Virus Replication in Canine Melanoma. Molecular Therapy - Oncolytics 15, pages 49-59.
Crossref
Crossref
Elham Zendedel, Stephen L. Atkin & Amirhossein Sahebkar. (2019) Use of stem cells as carriers of oncolytic viruses for cancer treatment. Journal of Cellular Physiology 234:9, pages 14906-14913.
Crossref
Crossref
Yoshihiro Miyagawa, Koji Araki, Taku Yamashita, Shingo Tanaka, Yuya Tanaka, Masayuki Tomifuji, Yasuji Ueda, Yoshikazu Yonemitsu, Hideaki Shimada & Akihiro Shiotani. (2019) Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase‐specific oncolytic Sendai virus. Head & Neck 41:9, pages 2873-2882.
Crossref
Crossref
Zhenping Cao, Shanshan Cheng, Xinyue Wang, Yan Pang & Jinyao Liu. (2019) Camouflaging bacteria by wrapping with cell membranes. Nature Communications 10:1.
Crossref
Crossref
Gabriel Scheubeck, Susanne Berchtold, Irina Smirnow, Andrea Schenk, Julia Beil & Ulrich M. Lauer. (2019) Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus. Viruses 11:7, pages 614.
Crossref
Crossref
Masaya Igase, Kazuha Shousu, Noriyuki Fujiki, Masashi Sakurai, Makoto Bonkobara, Chung C. Hwang, Matt Coffey, Shunsuke Noguchi, Yuki Nemoto & Takuya Mizuno. (2019) Anti‐tumour activity of oncolytic reovirus against canine histiocytic sarcoma cells. Veterinary and Comparative Oncology 17:2, pages 184-193.
Crossref
Crossref
Gang Meng, Ziwei Fei, Mingyue Fang, Binghua Li, Anxian Chen, Chun Xu, Mao Xia, Decai Yu & Jiwu Wei. (2019) Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma. Molecular Therapy - Oncolytics 13, pages 22-34.
Crossref
Crossref
Margarita GarcíaRafael MorenoMarta Gil-MartinManel CascallòMaria Ochoa de OlzaCarmen CuadraJosep Maria PiulatsValentin NavarroMarta DomenechRamon AlemanyRamon Salazar. (2019) A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients. Human Gene Therapy 30:3, pages 352-364.
Crossref
Crossref
Amanda L. Huff, Phonphimon Wongthida, Timothy Kottke, Jill M. Thompson, Christopher B. Driscoll, Matthew Schuelke, Kevin G. Shim, Reuben S. Harris, Amy Molan, Jose S. Pulido, Peter J. Selby, Kevin J. Harrington, Alan Melcher, Laura Evgin & Richard G. Vile. (2018) APOBEC3 Mediates Resistance to Oncolytic Viral Therapy. Molecular Therapy - Oncolytics 11, pages 1-13.
Crossref
Crossref
Chrisann Kyi, Vladimir Roudko, Rachel Sabado, Yvonne Saenger, William Loging, John Mandeli, Tin Htwe Thin, Deborah Lehrer, Michael Donovan, Marshall Posner, Krzysztof Misiukiewicz, Benjamin Greenbaum, Andres Salazar, Philip Friedlander & Nina Bhardwaj. (2018) Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial. Clinical Cancer Research 24:20, pages 4937-4948.
Crossref
Crossref
Margarita GarciaRafael MorenoMarta GilManel CascalloMaria Ochoa de OlzaCarmen CuadraJosep Maria PiulatValentin NavarroMarta DomenechRamon AlemanyRamon Salazar. (2018) A phase I trial of oncolytic adenovirus ICOVIR-5 administered intravenously to melanoma patients. Human Gene Therapy Clinical Development.
Crossref
Crossref
Amy MacNeill, Kristen Weishaar, Bernard Séguin & Barbara Powers. (2018) Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma. Viruses 10:8, pages 398.
Crossref
Crossref
Mathias Felix Leber, Marc-Andrea Baertsch, Sophie Caroline Anker, Luisa Henkel, Hans Martin Singh, Sascha Bossow, Christine E. Engeland, Russell Barkley, Birgit Hoyler, Jessica Albert, Christoph Springfeld, Dirk Jäger, Christof von Kalle & Guy Ungerechts. (2018) Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites. Molecular Therapy - Oncolytics 9, pages 30-40.
Crossref
Crossref
Yang Wang, Jing Jin, Zhen Wu, Sheng Hu, Han Hu, Zhifeng Ning, Yanfei Li, Yuting Dong, Jianwen Zou, Zeyong Mao, Xiaotai Shi, Huajun Zheng, Shuang Dong, Fuxing Liu, Zhizheng Fang, Jiliang Wu & Binlei Liu. (2018) Stability and anti-tumor effect of oncolytic herpes simplex virus type 2. Oncotarget 9:37, pages 24672-24683.
Crossref
Crossref
Adam W. Studebaker, Brian J. Hutzen, Christopher R. Pierson, Kellie B. Haworth, Timothy P. Cripe, Eric M. Jackson & Jeffrey R. Leonard. (2017) Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors. Molecular Therapy - Oncolytics 6, pages 22-30.
Crossref
Crossref
Marie Rouanet, Marine Lebrin, Fabian Gross, Barbara Bournet, Pierre Cordelier & Louis Buscail. (2017) Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes. International Journal of Molecular Sciences 18:6, pages 1231.
Crossref
Crossref
Yogesh R. Suryawanashi, Tiantian Zhang, Helene M. Woyczesczyk, John Christie, Emily Byers, Steven Kohler, Robert Eversole, Charles Mackenzie & Karim Essani. (2017) T-independent response mediated by oncolytic tanapoxvirus recombinants expressing interleukin-2 and monocyte chemoattractant protein-1 suppresses human triple negative breast tumors. Medical Oncology 34:6.
Crossref
Crossref
Carlos Alberto Fajardo, Sonia Guedan, Luis Alfonso Rojas, Rafael Moreno, Marcel Arias-Badia, Jana de Sostoa, Carl H. June & Ramon Alemany. (2017) Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor Efficacy. Cancer Research 77:8, pages 2052-2063.
Crossref
Crossref
Yasufumi Kaneda. (2017) Development and application of DDS to activate anti-tumor immunity. Drug Delivery System 32:3, pages 208-217.
Crossref
Crossref
Jianhua Chen, Pei Gao, Sujing Yuan, Rongxin Li, Aimin Ni, Liang Chu, Li Ding, Ying Sun, Xin-Yuan Liu & Yourong Duan. (2016) Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy. ACS Nano 10:12, pages 11548-11560.
Crossref
Crossref
Elena P. Goncharova, Julia S. Ruzhenkova, Ivan S. Petrov, Sergey N. Shchelkunov & Marina A. Zenkova. (2016) Oncolytic virus efficiency inhibited growth of tumour cells with multiple drug resistant phenotype in vivo and in vitro. Journal of Translational Medicine 14:1.
Crossref
Crossref
Hope Murphy, Hana Jaafari & Hana M. Dobrovolny. (2016) Differences in predictions of ODE models of tumor growth: a cautionary example. BMC Cancer 16:1.
Crossref
Crossref
Lianwen Zhang, Michael B Steele, Nathan Jenks, Jacquelyn Grell, Marshall Behrens, Rebecca Nace, Shruthi Naik, Mark J Federspiel, Stephen J Russell & Kah-Whye Peng. (2016) Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model. Molecular Therapy 24:12, pages 2109-2117.
Crossref
Crossref
Kristian Taipale, Ilkka Liikanen, Anniina Koski, Raita Heiskanen, Anna Kanerva, Otto Hemminki, Minna Oksanen, Susanna Grönberg-Vähä-Koskela, Kari Hemminki, Timo Joensuu & Akseli Hemminki. (2016) Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy. Molecular Therapy 24:7, pages 1323-1332.
Crossref
Crossref
Zahid Delwar, Kaixin Zhang, Paul S. Rennie & William Jia. (2016) Oncolytic virotherapy for urological cancers. Nature Reviews Urology 13:6, pages 334-352.
Crossref
Crossref
Autumn J. Ruiz, Elizabeth M. Hadac, Rebecca A. Nace & Stephen J. Russell. (2016) MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy. Journal of Virology 90:8, pages 4078-4092.
Crossref
Crossref
Adam Kaczorowski, Katharina Hammer, Li Liu, Sabine Villhauer, Clifford Nwaeburu, Pei Fan, Zhefu Zhao, Jury Gladkich, Wolfgang Groß, Dirk M. Nettelbeck & Ingrid Herr. (2016) Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells. Oncotarget 7:8, pages 9046-9059.
Crossref
Crossref
Georges VassauxAssia AngelovaPatrick BarilPatrick MidouxJean RommelaerePierre Cordelier. (2016) The Promise of Gene Therapy for Pancreatic Cancer. Human Gene Therapy 27:2, pages 127-133.
Crossref
Crossref
P-Y Wang, H M Swain, A L Kunkler, C-Y Chen, B J Hutzen, M A Arnold, K A Streby, M H Collins, B Dipasquale, J R Stanek, J Conner, T H van Kuppevelt, J C Glorioso, P Grandi & T P Cripe. (2015) Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility. Gene Therapy 23:2, pages 135-143.
Crossref
Crossref
Yi-Gang Wang. (2016) Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma. World Journal of Gastroenterology 22:1, pages 326.
Crossref
Crossref
Mari Hirvinen, Cristian Capasso, Kilian Guse, Mariangela Garofalo, Andrea Vitale, Marko Ahonen, Lukasz Kuryk, Markus Vähä-Koskela, Akseli Hemminki, Vittorio Fortino, Dario Greco & Vincenzo Cerullo. (2016) Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity. Molecular Therapy - Oncolytics 3, pages 16002.
Crossref
Crossref
Kristian Taipale, Ilkka Liikanen, Juuso Juhila, Riku Turkki, Siri T?htinen, Matti Kankainen, Lotta Vassilev, Ari Ristim?ki, Anniina Koski, Anna Kanerva, Iulia Diaconu, Vincenzo Cerullo, Markus V?h?-Koskela, Minna Oksanen, Nina Linder, Timo Joensuu, Johan Lundin & Akseli Hemminki. (2016) Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus. Molecular Therapy 24:1, pages 175-183.
Crossref
Crossref
Johanna K. Kaufmann & Dirk M. Nettelbeck. 2016. Adenoviral Vectors for Gene Therapy. Adenoviral Vectors for Gene Therapy
529
549
.
A. Tsun, X. N. Miao, C. M. Wang & D. C. Yu. 2016. Progress in Cancer Immunotherapy. Progress in Cancer Immunotherapy
241
283
.
Ottmar Herchenröder, Julia Reetz & Brigitte M. Pützer. 2016. Regenerative Medicine - from Protocol to Patient. Regenerative Medicine - from Protocol to Patient
13
40
.
G. Clement Dobbins, Hideyo Ugai, David T. Curiel & G. Yancey Gillespie. (2015) A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents. PLOS ONE 10:12, pages e0145272.
Crossref
Crossref
Dillon Betancourt, Juan Carlos Ramos & Glen N. Barber. (2015) Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia. Journal of Virology 89:23, pages 11786-11800.
Crossref
Crossref
Bing-Hua Su, Gia-Shing Shieh, Yau-Lin Tseng, Ai-Li Shiau & Chao-Liang Wu. (2015)
Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the
MDR1
promoter activity
. Oncotarget 6:35, pages 38308-38326.
Crossref
Crossref
A.C. Birkeland, J.H. Owen & M.E. Prince. (2015) Targeting Head and Neck Cancer Stem Cells. Journal of Dental Research 94:11, pages 1516-1523.
Crossref
Crossref
Gerard G. Hanna, Victoria M. Coyle & Kevin M. Prise. (2015) Immune modulation in advanced radiotherapies: Targeting out-of-field effects. Cancer Letters 368:2, pages 246-251.
Crossref
Crossref
Marcos F. Q. Sousa, Marta M. Silva, Daniel Giroux, Yas Hashimura, Robin Wesselschmidt, Brian Lee, António Roldão, Manuel J. T. Carrondo, Paula M. Alves & Margarida Serra. (2015) Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes. Biotechnology Progress 31:6, pages 1600-1612.
Crossref
Crossref
Katie Anderson & Jaime Modiano. (2015) Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure. Veterinary Sciences 2:4, pages 363-387.
Crossref
Crossref
Anniina Koski, Simona Bramante, Anja Kipar, Minna Oksanen, Juuso Juhila, Lotta Vassilev, Timo Joensuu, Anna Kanerva & Akseli Hemminki. (2015) Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues. Molecular Therapy 23:10, pages 1641-1652.
Crossref
Crossref
J. Michels, T. Yamasaki & L. Apetoh. (2015) Immunogénicité de la chimiothérapieImmunogenicity of Chemotherapy. Oncologie 17:9, pages 345-353.
Crossref
Crossref
Wen Zhang, Keli Ge, Qian Zhao, Xiufen Zhuang, Zhenling Deng, Lingling Liu, Jie Li, Yu Zhang, Ying Dong, Youhui Zhang, Shuren Zhang & Binlei Liu. (2015) A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4. Oncotarget 6:24, pages 20345-20355.
Crossref
Crossref
Claudia Cantoni, Korneel Grauwet, Gabriella Pietra, Monica Parodi, Maria Cristina Mingari, Andrea De Maria, Herman Favoreel & Massimo Vitale. (2015) Role of NK cells in immunotherapy and virotherapy of solid tumors. Immunotherapy 7:8, pages 861-882.
Crossref
Crossref
Douglas B Johnson, Igor Puzanov & Mark C Kelley. (2015) Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma. Immunotherapy 7:6, pages 611-619.
Crossref
Crossref
C-S Lu, J-L Hsieh, C-Y Lin, H-W Tsai, B-H Su, G-S Shieh, Y-C Su, C-H Lee, M-Y Chang, C-L Wu & A-L Shiau. (2015) Potent antitumor activity of Oct4 and hypoxia dual-regulated oncolytic adenovirus against bladder cancer. Gene Therapy 22:4, pages 305-315.
Crossref
Crossref
Carmela Passaro & Giuseppe Portella. (2015) Oncolytic virotherapy for thyroid cancer: will it translate to the clinic?. International Journal of Endocrine Oncology 2:1, pages 5-8.
Crossref
Crossref
Heather VanSeggelen, Daniela GM Tantalo, Arya Afsahi, Joanne A Hammill & Jonathan L Bramson. (2015) Chimeric antigen receptor–engineered T cells as oncolytic virus carriers. Molecular Therapy - Oncolytics 2, pages 15014.
Crossref
Crossref